InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by ADELMAN BURT A, Director. Director active across 1 companies, notably Verve Therapeutics, Inc.. Aggregated, 4 disclosures have been published. Total volume traded: €456k. The latest transaction was disclosed on 12 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
€117,08210,000 shares@ €11.708225.7% of flow
Common Stock
SEC:0000899243-22-018016:0·
Ideal exit: 6 Feb 2023 (T+270)
€78,1634,000 shares@ €19.540717.2% of flow
Common Stock
SEC:0000899243-22-011337:0·
Ideal exit: 10 Dec 2022 (T+270)
€130,1324,700 shares@ €27.6878100.0% of flow
Common Stock
SEC:0000899243-21-046887·
Ideal exit: 29 Aug 2022 (T+270)
€130,1324,700 shares@ €27.687828.6% of flow
Common Stock
SEC:0000899243-21-046887:0·
Ideal exit: 29 Aug 2022 (T+270)
4 of 4 declarations
About ADELMAN BURT A
Burt A. Adelman serves as a Director of Verve Therapeutics, Inc. As a board member, he contributes to overseeing the company's operations and making strategic decisions. Burt brings expertise in biotechnology, which is crucial for the growth and innovation of Verve. His commitment to corporate governance is essential for ensuring transparency and accountability.
